Astrana Health Reports Q3 Revenue Growth, Narrows 2026 Guidance
Astrana Health reported third-quarter 2026 revenue of $1.02 billion, up 7% year over year, and adjusted EBITDA of $77.2 million, up 13%. It narrowed its 2026 guidance ranges while maintaining their original midpoints.
Astrana Health, Inc. reported $1.02 billion in revenue for the third quarter of 2026, representing a 7% increase compared to the previous year, alongside an Adjusted EBITDA of $77.2 million, up 13%. The company narrowed its 2026 financial guidance ranges while maintaining the original midpoints. Additionally, Astrana Health finalized the acquisition of an independent physician association in Georgia on October 1, 2026.
The company also noted ongoing risks related to cybersecurity litigation and an unremediated material weakness in its internal control over financial reporting.